| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0010100 | Exon-Exon | chr3:171851261-171944737 | chr3:172133471-172226947 | 153 nt | 0.4510 |
| hsa_FNDC3B_0010200 | Exon-Exon | chr3:171851261-171969331 | chr3:172133471-172251541 | 679 nt | 0.4934 |
| hsa_FNDC3B_0010300 | Exon-Exon | chr3:171851261-172070873 | chr3:172133471-172353083 | 2684 nt | 0.4940 |
| hsa_chr3_0366700 | Intergenic-Intergenic | chr3:171889866-171890059 | chr3:172172076-172172269 | 194 nt | 0.3918 |
| hsa_FNDC3B_0012600 | Exon-Exon | chr3:171944661-171944737 | chr3:172226871-172226947 | 77 nt | 0.4935 |
| hsa_FNDC3B_0012700 | Exon-Exon | chr3:171944661-171965566 | chr3:172226871-172247776 | 321 nt | 0.5109 |
| hsa_FNDC3B_0012800 | Exon-Exon | chr3:171944661-171969331 | chr3:172226871-172251541 | 603 nt | 0.5041 |
| hsa_FNDC3B_0012900 | Exon-Exon | chr3:171944661-172016577 | chr3:172226871-172298787 | 874 nt | 0.4828 |
| hsa_FNDC3B_0013000 | Exon-Exon | chr3:171944661-172028671 | chr3:172226871-172310881 | 1067 nt | 0.4873 |
| hsa_FNDC3B_0014800 | Exon-Exon | chr3:171965323-171969331 | chr3:172247533-172251541 | 526 nt | 0.5057 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].